# A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)

> **NCT06962852** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 5 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **GENETIC:** BI 3720931

## Key facts

- **NCT ID:** NCT06962852
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2040-10-29
- **Final completion:** 2040-10-29
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06962852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06962852, "A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06962852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*